US Stock MarketDetailed Quotes

MDCX Medicus Pharma

Watchlist
  • 2.250
  • -0.400-15.09%
Trading Nov 15 10:30 ET
24.41MMarket Cap0.00P/E (TTM)

Medicus Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-63.92%-381.52K
24.80%-239.56K
27.00%-1.06M
-330.16K
-175.64K
Net income from continuing operations
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
2.08%-488.67K
-0.12%-483.92K
17.66%-1.69M
---322.21K
---387.79K
Depreciation and amortization
--26.04K
--26.04K
----
----
----
--0
--0
----
----
----
Other non cash items
-62.12%88.26K
-88.93%9.01K
131.17%1.65M
--0
1,047.54%1.34M
-2.96%232.98K
-62.23%81.39K
16.30%713.97K
--141.95K
--116.43K
Change In working capital
711.91%769.95K
212.75%509.72K
1,153.22%828.74K
-358.61%-687.42K
1,445.12%1.48M
-570.09%-125.83K
2,940.31%162.98K
-1,081.84%-78.69K
---149.89K
--95.72K
-Change in prepaid assets
--44.81K
753.07%61.64K
-958.13%-158.72K
-1,056.67%-173.5K
--7.56K
--0
--7.23K
---15K
---15K
--0
-Change in payables and accrued expense
676.29%725.14K
187.69%448.08K
1,650.49%987.46K
-280.98%-513.92K
1,437.23%1.47M
-570.09%-125.83K
2,814.38%155.75K
-856.55%-63.69K
---134.89K
--95.72K
Cash from discontinued investing activities
Operating cash flow
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-37.36%-381.52K
12.43%-239.56K
27.00%-1.06M
---330.16K
---175.64K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
350.15%5.61M
0
10,119.90%5.11M
41.24%1.25M
591.33K
50K
Net issuance payments of debt
----
----
-59.88%500K
--0
--0
----
----
41.24%1.25M
--591.33K
--50K
Net other financing activities
----
----
--5.11M
--0
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
----
----
350.15%5.61M
--0
10,119.90%5.11M
----
----
41.24%1.25M
--591.33K
--50K
Net cash flow
Beginning cash position
1,830.54%542.41K
542.38%1.72M
240.90%267.65K
78,726.31%5.11M
10.94%146.57K
-93.15%28.1K
240.90%267.65K
-87.81%78.51K
--6.48K
--132.12K
Current changes in cash
6,539.93%7.87M
-391.30%-1.18M
667.53%1.45M
-1,397.46%-3.39M
4,049.01%4.96M
142.66%118.48K
-172.30%-239.56K
133.44%189.14K
--261.17K
---125.64K
End cash Position
5,637.21%8.41M
1,830.54%542.41K
542.38%1.72M
542.38%1.72M
78,726.31%5.11M
10.94%146.57K
-93.15%28.1K
240.90%267.65K
--267.65K
--6.48K
Free cash flow
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-37.36%-381.52K
12.43%-239.56K
27.00%-1.06M
---330.16K
---175.64K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unaudited
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-63.92%-381.52K24.80%-239.56K27.00%-1.06M-330.16K-175.64K
Net income from continuing operations -745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M2.08%-488.67K-0.12%-483.92K17.66%-1.69M---322.21K---387.79K
Depreciation and amortization --26.04K--26.04K--------------0--0------------
Other non cash items -62.12%88.26K-88.93%9.01K131.17%1.65M--01,047.54%1.34M-2.96%232.98K-62.23%81.39K16.30%713.97K--141.95K--116.43K
Change In working capital 711.91%769.95K212.75%509.72K1,153.22%828.74K-358.61%-687.42K1,445.12%1.48M-570.09%-125.83K2,940.31%162.98K-1,081.84%-78.69K---149.89K--95.72K
-Change in prepaid assets --44.81K753.07%61.64K-958.13%-158.72K-1,056.67%-173.5K--7.56K--0--7.23K---15K---15K--0
-Change in payables and accrued expense 676.29%725.14K187.69%448.08K1,650.49%987.46K-280.98%-513.92K1,437.23%1.47M-570.09%-125.83K2,814.38%155.75K-856.55%-63.69K---134.89K--95.72K
Cash from discontinued investing activities
Operating cash flow -616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-37.36%-381.52K12.43%-239.56K27.00%-1.06M---330.16K---175.64K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 350.15%5.61M010,119.90%5.11M41.24%1.25M591.33K50K
Net issuance payments of debt ---------59.88%500K--0--0--------41.24%1.25M--591.33K--50K
Net other financing activities ----------5.11M--0------------------------
Cash from discontinued financing activities
Financing cash flow --------350.15%5.61M--010,119.90%5.11M--------41.24%1.25M--591.33K--50K
Net cash flow
Beginning cash position 1,830.54%542.41K542.38%1.72M240.90%267.65K78,726.31%5.11M10.94%146.57K-93.15%28.1K240.90%267.65K-87.81%78.51K--6.48K--132.12K
Current changes in cash 6,539.93%7.87M-391.30%-1.18M667.53%1.45M-1,397.46%-3.39M4,049.01%4.96M142.66%118.48K-172.30%-239.56K133.44%189.14K--261.17K---125.64K
End cash Position 5,637.21%8.41M1,830.54%542.41K542.38%1.72M542.38%1.72M78,726.31%5.11M10.94%146.57K-93.15%28.1K240.90%267.65K--267.65K--6.48K
Free cash flow -616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-37.36%-381.52K12.43%-239.56K27.00%-1.06M---330.16K---175.64K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unaudited--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data